ImmunoHorizons: 6 (6)

June 1, 2022; Volume 6,Issue 6

ADAPTIVE IMMUNITY

Open Access
Durable Immunity to Ricin Toxin Elicited by Intranasally Administered Monoclonal Antibody–Based Immune Complexes
Lindsey E. Tolman, Jennifer L. Yates, Yinghui Rong, Claire Reynolds-Peterson, Dylan Ehrbar, Fernando J. Torres-Velez and Nicholas J. Mantis

ImmunoHorizons June 1, 2022, 6 (6) 324-333; DOI: https://doi.org/10.4049/immunohorizons.2100105

Open Access
IL-10 and TGF-β Increase Connexin-43 Expression and Membrane Potential of HL-1 Cardiomyocytes Coupled with RAW 264.7 Macrophages
Cora B. Cox, Mike Castro, Thomas L. Brown and Nancy J. Bigley

ImmunoHorizons June 1, 2022, 6 (6) 334-343; DOI: https://doi.org/10.4049/immunohorizons.2100104
Open Access
Inhibition of NETosis by a Nuclear-Penetrating Anti-DNA Autoantibody
Xiaoyong Chen, Benedette J. Cuffari, Valentina Dubljevic, Anupama Shirali, Jiangbing Zhou, James A. Campbell, Stephen C. Suits, Kim M. O’Sullivan and James E. Hansen

ImmunoHorizons June 1, 2022, 6 (6) 356-365; DOI: https://doi.org/10.4049/immunohorizons.2100091
Open Access
Longitudinal T Cell Responses against Ancestral, Delta, and Omicron SARS-CoV-2 Variants Determined by Rapid Cytokine Release Assay in Whole Blood
Maria A. Oliver, Rhys T. Meredith, Bryan R. Smith, Max D. Bermingham, Nicole F. Brackett and Martin D. Chapman

ImmunoHorizons June 1, 2022, 6 (6) 398-407; DOI: https://doi.org/10.4049/immunohorizons.2200044

Open Access
Severe Acute Respiratory Syndrome Coronavirus 2 Epitope Mapping for Antibodies
Jiaan Yang, Peng Zhang, Wen Xiang Cheng, Gang Wu, Qing Tian Niu, Lan Yang, Shun Luo, Xianghua Lin and Lianshan Zhang

ImmunoHorizons June 1, 2022, 6 (6) 344-355; DOI: https://doi.org/10.4049/immunohorizons.2200030
Open Access
A Hemagglutinin 1 Carrying Plant-Based Virus-like Particle Vaccine Generates an Efficacious Cellular Response by Exploiting IL-1 Signaling in Both Adult and Aged Mice
Fernando Alvarez, Roman Istomine, Hilary Hendin, Breanna Hodgins, Stephane Pillet, Jörg H. Fritz, Nathalie Charland, Brian J. Ward and Ciriaco A. Piccirillo

ImmunoHorizons June 1, 2022, 6 (6) 384-397; DOI: https://doi.org/10.4049/immunohorizons.2200036
Open Access
Level and Duration of IgG and Neutralizing Antibodies to SARS-CoV-2 in Children with Symptomatic or Asymptomatic SARS-CoV-2 Infection
Alka Khaitan, Dibyadyuti Datta, Caitlin Bond, Michael Goings, Katrina Co, Eliud O. Odhiambo, Lucy Miller, Lin Zhang, Stephanie Beasley, Josh Poorbaugh and Chandy C. John

ImmunoHorizons June 1, 2022, 6 (6) 408-415; DOI: https://doi.org/10.4049/immunohorizons.2200029

Open Access
RXRα Regulates the Development of Resident Tissue Macrophages
Jordan Philpott, Simon Kazimierczyk, Parimal Korgaonkar, Evan Bordt, Jaclyn Zois, Chithirachelvi Vasudevan, Di Meng, Ishan Bhatia, Naifang Lu, Brittany Jimena, Caryn Porter, Bobby J. Cherayil and Nitya Jain

ImmunoHorizons June 1, 2022, 6 (6) 366-372; DOI: https://doi.org/10.4049/immunohorizons.2200019
Open Access
Alboserpin, the Main Salivary Anticoagulant from the Disease Vector Aedes albopictus, Displays Anti–FXa-PAR Signaling In Vitro and In Vivo
Gaurav Shrivastava, Paola Carolina Valenzuela-Leon, Andrezza Campos Chagas, Olivia Kern, Karina Botello, Yixiang Zhang, Ines Martin-Martin, Markus Berger Oliveira, Lucas Tirloni and Eric Calvo

ImmunoHorizons June 1, 2022, 6 (6) 373-383; DOI: https://doi.org/10.4049/immunohorizons.2200045